NeoGenomics
- Market cap
- 2.05B
- P/E (TTM)i
- -40.95
- P/Bi
- 2.61
- EPSi
- -0.84
- Div yieldi
- 0.00%
- 52W posi
- 68%
Anonymous reader poll. Unscientific, not investment advice.
Shares of NeoGenomics closed at 15.97, down 3.24%. That leaves the company valued at approximately 2.05B, the #2660 most valuable US-listed company we track. The 8 analysts covering the stock are, on balance, at Buy, targeting an average of 18.33 (+15%). Against a 52-week band of 7.07-20.15, the shares are currently 68% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 10% of the universe, above its 200-day average.
- Signal has read BUY for 4 months.
- Its last 4 Buy calls have averaged +7% over the following quarter.
- Recent price momentum is +43.5% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 13.0% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 16.51
- Open
- 16.36
- Day range
- 15.88 - 16.64
- Avg price
- 16.09
- Volume
- 3.19M
- Turnover
- 51.35M
- Turnover ratei
- 2.73%
- Volume ratioi
- 1.11
- Amplitudei
- 4.60%
- 52-week rangei
- 7.07 - 20.15
Valuation
- P/Ei
- -19.01
- P/E (TTM)i
- -40.95
- P/Bi
- 2.61
- EPSi
- -0.84
- Book value / shi
- 6.12
- Net profit
- -107.92M
- Net assets
- 785.76M
Share structure
- Market cap
- 2.05B
- Float capi
- 1.87B
- Shares out
- 128.48M
- Float sharesi
- 117.02M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
20.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+5.68M net over the window
Short interest
- Shares short
- 16.71M
- % of floati
- 13.01%
- Days to coveri
- 11.18
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of NeoGenomics (NEO)?
NeoGenomics last traded at 15.97. The quote on this page refreshes every few seconds while US markets are open.
What is NeoGenomics's market cap?
About 2.05B.
What is the P/E ratio of NeoGenomics?
The trailing twelve-month P/E is -40.95. The Valuation tab shows it against the stock's own five-year range.
Does NeoGenomics pay a dividend?
NeoGenomics does not currently pay a regular dividend.
Is NeoGenomics a buy according to analysts?
The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 18.33, which implies 14.8% upside from the current price. This is not investment advice.
What is NeoGenomics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates NeoGenomics a B (Buy). Twelve-month momentum in the top 10% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 07:08:37 · For reference only, not investment advice and not tailored to your situation.